Mark, if im not mistaken the short sale amount at .02 would be much greater than that. I believe the short play was from .30 cents on the sale and .02 on the buy. I believe your profit would be the difference between the two numbers multiplied by the amount of shares. Or I could be wrong and they could have shorted any where from .50 and up to a dollar. The higher the short sale starting point the better.
When news broke out of the clinical trial being inconclusive we were trading about $1.00 to $1.20. I think they have room to cover thier positons at this point. You may not think that this position is relevent but to cover that many shares could jump the stock price considerably.
"Do you think Cobalis who has never sold or marketed a product ever is going to manufacture, brand, advertise and then sell millions of dollars of product in the next 4-5 months. As of October this was still a licensing deal. You people need to have realistic expectations of what it takes to actually launch and market a new product. We may all have been desperately waiting for this day to come but the world hasn't."
Hey Mr Sandiego or should I say Mr Negative. Two weeks left to prove you wrong!!
Market Data 
Markets 
AI
